Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy-Reference-Cited by-同舟云学术

Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy

Published:2008-10 Issue:10 Volume:14 Page:1387-1391
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Zabana Yamile,Domènech Eugeni,San Román Antonio López,Beltrán Belén,Cabriada José Luis,Saro Cristina,Araméndiz Robert,Ginard Daniel,Hinojosa Joaquín,Gisbert Javier P.,Mañosa Míriam,Cabré Eduard,Gassull Miquel A.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference23 articles.

1. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

3. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

4. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

5. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU;Journal of Clinical Medicine;2022-07-05

2. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies;Gastroenterología y Hepatología (English Edition);2021-10

3. Riesgo de infección asociado a los inhibidores de las quinasas Janus (JAK) y las terapias biológicas en enfermedad inflamatoria intestinal y artritis reumatoide. Estrategias de prevención;Gastroenterología y Hepatología;2021-10

4. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2021-03-17

5. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la infección tuberculosa en pacientes con enfermedad inflamatoria intestinal;Gastroenterología y Hepatología;2021-01